UBS Group’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.64K Buy
3,047
+2,785
+1,063% +$6.07K ﹤0.01% 7751
2025
Q1
$314 Sell
262
-1,234
-82% -$1.48K ﹤0.01% 8512
2024
Q4
$2.54K Buy
1,496
+1,236
+475% +$2.1K ﹤0.01% 7786
2024
Q3
$611 Sell
260
-48
-16% -$113 ﹤0.01% 7650
2024
Q2
$899 Sell
308
-718
-70% -$2.1K ﹤0.01% 7577
2024
Q1
$3.12K Buy
1,026
+766
+295% +$2.33K ﹤0.01% 6598
2023
Q4
$738 Sell
260
-3,904
-94% -$11.1K ﹤0.01% 7313
2023
Q3
$11.2K Buy
4,164
+3,904
+1,502% +$10.5K ﹤0.01% 5927
2023
Q2
$416 Sell
260
-5,013
-95% -$8.02K ﹤0.01% 7163
2023
Q1
$11.8K Buy
5,273
+5,012
+1,920% +$11.2K ﹤0.01% 6384
2022
Q4
$991 Sell
261
-2,600
-91% -$9.87K ﹤0.01% 8802
2022
Q3
$11K Buy
2,861
+2,554
+832% +$9.82K ﹤0.01% 7171
2022
Q2
$4K Buy
+307
New +$4K ﹤0.01% 7995
2022
Q1
Sell
-732
Closed -$20K 9147
2021
Q4
$20K Buy
732
+653
+827% +$17.8K ﹤0.01% 6712
2021
Q3
$5K Buy
79
+33
+72% +$2.09K ﹤0.01% 7365
2021
Q2
$5K Sell
46
-87
-65% -$9.46K ﹤0.01% 7422
2021
Q1
$20K Sell
133
-220
-62% -$33.1K ﹤0.01% 6352
2020
Q4
$42K Buy
+353
New +$42K ﹤0.01% 5335
2020
Q3
Sell
-130
Closed -$36K 7069
2020
Q2
$36K Buy
130
+106
+442% +$29.4K ﹤0.01% 5292
2020
Q1
$8K Buy
24
+8
+50% +$2.67K ﹤0.01% 6147
2019
Q4
$3K Buy
+16
New +$3K ﹤0.01% 6652
2019
Q3
Sell
-22
Closed -$8K 6989
2019
Q2
$8K Sell
22
-23
-51% -$8.36K ﹤0.01% 6297
2019
Q1
$15K Buy
+45
New +$15K ﹤0.01% 5695
2018
Q4
Sell
-42
Closed -$23K 7061
2018
Q3
$23K Buy
42
+29
+223% +$15.9K ﹤0.01% 5804
2018
Q2
$13K Buy
13
+12
+1,200% +$12K ﹤0.01% 6052
2018
Q1
$2K Buy
+1
New +$2K ﹤0.01% 6618
2017
Q4
Hold
0
6541